Cancer Stem Cells Market

Cancer Stem Cells Market Size, Share & Trends Analysis Report

Cancer Stem Cells Market Size, Share 2020 To 2025, Business Stats, Growth Perspective And Forecast 2025

Report ID : BMRC 365
Number of pages : 300
Published Date : Nov 2022
Category : Healthcare
Delivery Timeline : 48 hrs

Cancer Stem Cells Market is valued at USD 827.2 Million in 2018 and expected to reach USD 1717.4 Million by 2025 with the CAGR of 11.0% over the forecast period.

Scope of Global Cancer Stem Cells Market Report–

The cancer stem cells (CSC) are the cells of cancer (which are found inside hematological growths of tumors) which have qualities associated with ordinary stem cells, particularly the capability to offer ascent to all types of cell found in a specific sample of cancer. Cancer stem cells are a minor subpopulation of cells inside tumors with capabilities of self-renewal, differentiation, and tumorigenicity when transplanted into an animal host. A quantity of cell surface markers such as CD44, CD24, and CD133 are often used to identify and enrich CSCs. The CSCs are subsequently tumorigenic, may be rather than other non-tumorigenic cells of cancer. The CSCs can create tumor through the processes of stem cell of differentiation and self-renewal into various types of cells. Cancer stem cells are planned to breed in tumors as a separate population and thereby cause weakening and metastasis of existing tumor through generation of new tumor.

Global cancer stem cells market report is segmented on the basis of treatment type, disease type, application, end-user and regional & country level. Based on treatment type global cancer stem cells market is classified as autologous stem cell transplants, allogeneic stem cell transplants, syngeneic stem cell transplants and bone marrow stem cell transplants. Based upon disease type, global cancer stem cells market is classified into breast cancer, blood cancer, lung cancer, brain cancer, colorectal cancer, pancreatic cancer, bladder cancer, liver cancer and others. Based upon application, global cancer stem cells market is classified as musculoskeletal disorders, neurodegenerative disorders, cardiovascular diseases, gastrointestinal diseases, autoimmune disorders, wounds and injuries, surgeries, malignancies and dermatology. Based upon end-user, global cancer stem cells market is classified as hospitals and surgical centers, pharmaceutical and biotech companies, cell banks and tissue banks, academic institutes, research laboratories, and CROs and others.

The regions covered in this Global Cancer Stem Cells Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of cancer stem cells is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players -

Global cancer stem cells market report covers prominent players like AbbVie Inc., Advanced Cell Diagnostics Inc., Athersys Inc., AVIVA Biosciences, Beckton Dickson and Company, Bionomics, Epic Sciences, Immunocellular Therapeutics Ltd, JCR Pharmaceuticals, LONZA Group AG, MEDIPOST, Merck KGA, Novartis, Osiris Therapeutics, Oncomed Pharmaceuticals, Pfizer, Stemline Therapeutics Inc., Stemcell Technologies, Takara Bio Inc., Thermo Fischer Scientific Inc. and others.

Market Dynamics–

Worldwide cancer research activities are increasing rapidly due to the rising burden of mortality rate of cancer. Cancer stem cells are under research for various types of cancers such as lung cancer, breast cancer, colorectal cancer, skin cancer, brain cancer and bone cancer. According to World Health Organization (WHO), the global cancer burden has enhanced to 18.1 million new cases. The number of mortality rate due to cancer was 9.6 million in 2018. Additionally, Government initiative to boost the cancer research activities and availability of funds are some of the other major factors that are driving the global cancer stem cells (CSCs) market. However, high operational costs associated with the manufacturing process; rigid guidelines for clinical trials and regulatory challenges related to approvals inhibit the growth of the market.

Regional Analysis –

North America holds a dominating position in the global cancer stem cells market followed by Europe and Asia Pacific. Reasons such as highly developed research infrastructure, well defined regulatory norms, availability of research funds, availability of skilled research and healthcare professionals and supportive economy are driving the North American cancer stem cells market growth. Asia Pacific is expected to witness a significant growth in the global cancer stem cells. Governments in the Asia Pacific countries mainly in India and China are taking initiatives to boost the healthcare and biotechnology industry in the respective countries and thus, research and development activities in these countries are rapidly increasing. 

Key Benefits for Market Report–

  • Global Cancer Stem Cells Market report covers in depth historical and forecast analysis.
  • Global Cancer Stem Cells Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Cancer Stem Cells Market report helps to identify opportunities in market place.
  • Global Cancer Stem Cells Market report covers extensive analysis of emerging trends and competitive landscape.

Market Segmentation:–

By Treatment Type:

  • Autologous Stem Cell Transplants
  • Allogeneic Stem Cell Transplants
  • Syngeneic Stem Cell Transplants
  • Bone Marrow Stem Cell Transplants

By Disease Type:

  • Breast Cancer
  • Blood Cancer
  • Lung Cancer
  • Brain Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • Bladder Cancer
  • Liver Cancer
  • Others

By Application:

  • Musculoskeletal disorders
  • Cardiovascular diseases
  • Neurodegenerative disorders
  • Gastrointestinal diseases
  • Autoimmune Disorders
  • Wounds and injuries
  • Surgeries
  • Malignancies
  • Dermatology

By End-User:

  • Hospitals and Surgical Centers
  • Academic Institutes, Research Laboratories and CROs
  • Pharmaceutical and Biotech Companies
  • Cell Banks and Tissue Banks
  • Others

By Regional & Country Analysis:

  • North America
    • US.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
  • Rest of Middle East and Africa